Pahor D, Pahor A
Department of Ophthalmology, University Clinical Centre Maribor, Slovenia.
Department of Rheumatology and Immunology, University Clinical Centre Maribor, Slovenia.
Klin Monbl Augenheilkd. 2016 Oct;233(10):1156-1162. doi: 10.1055/s-0042-102963. Epub 2016 Jul 6.
To present the surgical management of perforated corneal ulcer using PRECLUDE® Pericardial Membrane, composed of expanded polytetrafluoroethylene (e-PTFE; GORE-TEX®), as an alternative surgical procedure in patients at high risk of graft rejections and to evaluate side effects for a prolonged period. The study included all patients who were admitted to our department and underwent surgical repair of perforated corneal ulcer with the e-PTFE membrane between 2010 and 2015. In total, 8 patients (8 eyes) were enrolled. Medical records of all patients were retrospectively reviewed. The operation was performed under peribulbar anaesthesia. Non-absorbable, microporous, watertight 0.1 mm thick e-PTFE membrane was used to close the corneal ulcer. The membrane was cut to overlap the defect adequately and to achieve the desired tissue attachment without preparing the conjunctiva or superficial trephination of the cornea. The membrane was fixed to the healthy cornea with several non-absorbable sutures (Prolene® 10.0), in order to achieve the proper stress without wrinkling. Five of 8 patients were treated for systemic immunological diseases. Sjögren's syndrome was diagnosed in 2 patients, granulomatosis with polyangiitis in one, vasculitis with a history of previous sclerokeratitis in one and systemic lupus erythematosus in one. In 2 patients, corneal perforation was observed as a complication of corneal infection and in one patient as a late complication of a severe chemical burn. Corneal perforations were successfully covered with e-PTFE membrane in all patients. E-PTFE membrane was well tolerated in all patients and the eye was always preserved. After 3 to 4 months, the membrane was removed in 7 patients. The underlying cornea was thin, firm, stable and vascularised. In one patient with Sjögren's syndrome, the e-PTFE membrane is still in place. Surgical management of perforated corneal ulcer using E-PTFE membrane may be the method of choice for eye preservation or for delayed corneal transplantation. Our results confirmed that the procedure is safe and effective, especially in high risk patients. After removing the membrane, penetrating keratoplasty can be performed as a definitive treatment in all eyes where an improvement in visual acuity is expected.
介绍使用由膨体聚四氟乙烯(e-PTFE;戈尔特斯®)制成的PRECLUDE®心包膜对穿孔性角膜溃疡进行手术治疗,作为移植排斥高风险患者的一种替代手术方法,并长期评估其副作用。该研究纳入了2010年至2015年间入住我科并接受e-PTFE膜穿孔性角膜溃疡手术修复的所有患者。总共纳入了8例患者(8只眼)。对所有患者的病历进行了回顾性分析。手术在球周麻醉下进行。使用不可吸收、微孔、防水的0.1毫米厚e-PTFE膜封闭角膜溃疡。将膜裁剪后充分覆盖缺损,无需制备结膜或对角膜进行浅表环钻即可实现所需的组织附着。用几根不可吸收缝线(普理灵®10.0)将膜固定在健康角膜上,以达到适当张力且无褶皱。8例患者中有5例患有全身性免疫疾病。2例诊断为干燥综合征,1例为肉芽肿性多血管炎,1例为有既往巩膜角膜炎病史的血管炎,1例为系统性红斑狼疮。2例患者角膜穿孔是角膜感染的并发症,1例患者角膜穿孔是严重化学烧伤的晚期并发症。所有患者的角膜穿孔均成功用e-PTFE膜覆盖。所有患者对e-PTFE膜耐受性良好,眼球均得以保留。3至4个月后,7例患者的膜被移除。下方角膜薄、坚韧、稳定且有血管化。1例干燥综合征患者的e-PTFE膜仍在位。使用e-PTFE膜对穿孔性角膜溃疡进行手术治疗可能是保眼或延迟角膜移植的首选方法。我们的结果证实该手术安全有效,尤其是在高风险患者中。移除膜后,对于预期视力会改善的所有眼睛,可进行穿透性角膜移植作为确定性治疗。